Policy Support and Industrial Innovation: Dongjiu Xinyi Medical Device Closed-Door Conference Successfully Held
In recent years, China’s life sciences, healthcare, and broader health industry has experienced rapid growth, emerging as a significant driver of the national economy. As one of China’s key economic hubs, Shanghai boasts robust economic strength and a highly internationalized business environment, providing a solid foundation for the development of this sector and holding a pivotal position within China’s life sciences, healthcare, and health industry landscape.
Shanghai’s Changning District has demonstrated strong momentum in the development of the medical and broader health industry in recent years. To further promote high-quality growth in this sector, the Changning District Government has introduced a series of supportive policies aimed at building a distinctive and robust life and health industry system. By establishing Life Yuanshan as a benchmark industrial park, the district seeks to create an exceptional environment for development and business operations.
On March 28, the “Airport-Economy Empowerment · Diversified Symbiosis” 2024 DNE Group Medical Device Enterprise Closed-Door Exchange Meeting, guided by the Donghong Office, hosted by DNE Group, and organized by VCBeat, was successfully held at Life Yuanshan in Changning District, Shanghai.
Zhang Fengjie, Chief of the Enterprise Services Section of the Changning District Commission of Commerce; Dong Lin, Head of the Changning Biopharmaceutical Registration Guidance Service Station; Guo Zhenhao, Deputy Director of the Linkong Park Business Environment Service Center and Director of the Policy Research Office of the Strategic Development Department of the District Donghong Office; Zhang Bin, Deputy Manager of the Southern Area Business Division of Linkong Park; Chen Feifei, Supervisor of Business Planning in the Southern Area Business Division of Linkong Park; Liu Jing, Supervisor of Business Planning in the Southern Area Business Division of Linkong Park; and Lu Jia, Senior Director of DNE Group and General Manager of the Life Yuan Shan Project, attended the meeting. Participants included the DNE Group operations team, heads of medical device startups such as Biogen Jiayi and Weimu Medical, and investors.
On-Site Exchange at the Closed-Door Meeting
Shanghai’s Changning District has demonstrated strong momentum in the development of the medical and general health industry in recent years. To further promote high-quality growth in this sector, the Changning District Government has introduced a series of supportive policies aimed at building a distinctive and robust life and health industry system.
During the 14th Five-Year Plan period, in addition to fostering its three advantageous industries—aviation services, “Internet Plus” consumer services, and fashion and creative industries—Changning District has also focused its development efforts on the life and health industry. Currently, Changning District has gathered more than 1,300 life and health enterprises, with tax revenue growth exceeding 25% for four consecutive years. It has established a number of R&D and commercialization centers, such as the Sai’ao Biological Research Center, attracted leading companies in the medical device sector, including Sinopharm and Danaher, and hosted several functional platforms, such as the Shanghai Food and Drug Safety Research Association and the Shanghai Beauty and Health Industry Association.
To accelerate the layout of the upstream and downstream life and health industry chains in Changning District and promote the aggregation of innovation and industrial resources, Changning District has promoted the construction of the Greater Hongqiao Life Science Innovation Center. During the 2023 Shanghai International Biopharmaceutical Industry Week, Changning District hosted the Life Science Innovation Development Summit, which was attended by more than 200 domestic and overseas enterprises. The Phase I project of the Greater Hongqiao Life Science Innovation Center was officially unveiled at Shengming Yuanshan (Life Meta Mountain). Following the unveiling, Shengming Yuanshan introduced a batch of life and health enterprises.
Furthermore, the Changning District Commission of Commerce, the Market Regulation Administration, and the Donghong Office have joined forces to introduce the Shanghai Institute for Medical Device Testing’s Greater Hongqiao Service Station and the Shanghai Biomedical Product Registration Service Workstation into Life Yuanshan. By integrating the professional services of these stations with the dedicated support provided by the Linkong Park and supplementing them with public services from government departments, this initiative aims to enhance the comprehensive competitiveness of Life Yuanshan.
To drive the development of the life and health industry, Changning District has adopted a multi-dimensional approach by providing policy support and services, building infrastructure, vigorously attracting talent, optimizing the business environment, and facilitating corporate financing and market expansion. Through these measures, the district is committed to creating an ecosystem conducive to the growth and innovation of medical device enterprises.
In driving the development of the life and health industry, the Linkong Park has shouldered the critical mission of facilitating industrial upgrading and economic growth in Changning District. One of the development goals of Linkong Park is to build an internationally advanced and domestically leading biopharmaceutical technology hub. As a key component in achieving this goal, Life Yuan Shan serves as a vital element in advancing the life and health industry.
On-Site Exchange Between Government and Enterprise Representatives
This conference provided a detailed introduction to the Shengming Yuanshan Park and local policies.DNE Group is committed to fostering a conducive environment for the development of medical device enterprises by leveraging multiple dimensions, including spatial infrastructure, supporting services, industrial ecosystems, innovation resources, financial support, and talent acquisition.
DNE Group positions the Shengming Yuanshan Park as a specialized park for the medical device industry, committed to building an influential cluster for the medical device industry in the Yangtze River Delta region.In terms of geographical location,Located in the core area of the Hongqiao Business District, Life Yuan Shan boasts convenient transportation, being only a 5-minute drive from the Hongqiao Transportation Hub and within a 1-minute drive to both the Middle Ring Road and Outer Ring Road, with Pudong International Airport accessible within 30 minutes. The park covers an area of 67 mu, with a total gross floor area of 80,000 square meters, offering medical device enterprises diverse space options for R&D offices and pilot-scale production. Additionally, support is provided in areas such as tenant fit-outs and rental incentives.
In terms of industrial ecosystem and innovation resources,Leveraging DNE Group’s industrial resources across China and globally, Life Yuan Shan integrates high-quality medical device enterprises from both domestic and international markets. It focuses on building a comprehensive industry chain that covers key stages including medical device design, incubation, technology transfer, manufacturing, and marketing. Meanwhile, the park will collaborate with universities, research institutes, and other innovation resources to establish a technological innovation platform, promote the integration of medicine and engineering, and accelerate the R&D and industrialization of medical devices.
Meanwhile,Life Yuan Shan provides comprehensive supporting services and financial backing.The industrial park has introduced third-party professional institutions to provide enterprises with comprehensive support services, including registration and filing, legal, financial and tax affairs, and intellectual property management, thereby creating a "one-stop" service platform. It also regularly hosts industry forums, project roadshows, and other activities to facilitate corporate exchange and collaboration. With its own industrial fund reaching RMB 10 billion in scale, DNE Group will prioritize investment in high-quality medical device projects within the park, assist enterprises in diversifying their financing channels, and leverage its accumulated resources in human capital to recruit top-tier talent in the medical device sector from both domestic and international markets for the park’s enterprises.
At this closed-door meeting, the government, industrial park authorities, and enterprises engaged in efficient interactive exchanges. Twelve medical device companies, including Bangce, Aibo Hechuang, Pulukang Pharmaceutical, and Ruidi Biotechnology, covering all segments of the medical device industry chain, actively participated in the discussion. Company representatives spoke individually on their corporate profiles and development needs, and engaged in lively discussions on issues such as “how to accelerate the review and registration process” and “how to expand sales channels and leverage industrial park resources to explore markets.”